Large gap with delayed quotes
|
Last quote
05/29/2026
-
17:31:09
|
Bid
05/29/2026 -
17:40:00
|
Bid Volume |
Ask
05/29/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
21.34
+0.02
(
+0.09% )
|
21.24
|
480 |
21.76
|
900 |
Analysis date: 29.05.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 21.04.2026.
Interest
Very weak
Very weak
One star since 15.05.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 28.04.2026 at a price of 21.92.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 21.04.2026.
4wk Rel Perf
-5.85%
-5.85%
The four-week dividend-adjusted underperformance versus STOXX600 is 5.85%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 17.03.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.68%.
Mkt Cap in $bn
1.07
1.07
With a market capitalization <$2bn, KUROS BIOSCIENCES is considered a small-cap stock.
G/PE Ratio
1.16
1.16
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
47.23
47.23
The estimated PE is for the year 2027.
LT Growth
54.87%
54.87%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
108
108
For 1% of index variation, the stock varies on average by 1.08%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
7.44
7.44
The value at risk is estimated at CHF 7.44. The risk is therefore 34.86%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.02.2026
03.02.2026